Robertson, Alan J.
Tran, Khoa A.
Bennett, Carmen
Sullivan, Clair
Stark, Zornitza
Vadlamudi, Lata
Waddell, Nicola
Funding for this research was provided by:
Digital Health CRC (DHCRC0083)
Article History
Received: 6 December 2023
Accepted: 23 March 2024
First Online: 2 April 2024
Competing interests
: AR is the founder and director of ClearSKY Genomics. ClearSKY Genomics is developing a genome browser for clinical use. This platform enables clinicians to better visualise genetic variants in their patients’ DNA, and communicate these findings to their patients. The work presented in this manuscript is independent from the work carried out by ClearSKY Genomics. ClearSKY Genomics has no financial interest in the software tools described here. NW is a co-founder of genomiQa, a spin out company from QIMR Berghofer. genomiQa specializes in clinical whole genome analysis for patient diagnosis and treatment selection. GenomiQa has no financial interest in the software described here.